A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cellsPeter J. Cook, David J. Rawlings, Chester Jacobs et al.|Molecular Therapy|2023Cited by 25
Enabling Gene-Edited, Regulatory-like, T Cells (edTreg) for Treatment of IPEX and Other Autoimmune DisordersYuchi Honaker, David J. Rawlings, Karen Sommer et al.|Blood|2019Cited by 4
Manufacture and In Vivo Support of Gene-Edited, Regulatory-like, T-Cells (edTreg) Using a Synthetic IL2 ReceptorGene Uenishi, Greg J. Cost, Cornell Mallari et al.|Blood|2019Cited by 0